{"DataElement":{"publicId":"3377212","version":"1","preferredName":"Liver Cancer American Joint Committee on Cancer (AJCC) Edition 7 Pathologic Tumor T Stage","preferredDefinition":"Extent of the primary hepatocellular carcinoma based on evidence obtained from pathologic examination through completion of definitive surgery.","longName":"3179611v1.0:3376979v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3179611","version":"1","preferredName":"Liver Cancer Pathologic T Stage","preferredDefinition":"A malignant tumor that arises from hepatocytes. Hepatocellular carcinoma is relatively rare in the United States but very common in all African countries south of the Sahara and in Southeast Asia. Most cases are seen in patients over the age of 50 years, but this tumor can also occur in younger individuals and even in children. Hepatocellular carcinoma is more common in males than females and is associated with hepatitis B, hepatitis C, chronic alcohol abuse and cirrhosis. Serum elevation of alpha-fetoprotein occurs in a large percentage of patients with hepatocellular carcinoma. Grossly, hepatocellular carcinoma may present as a single mass, as multiple nodules, or as diffuse liver involvement. Microscopically, there is a wide range of differentiation from tumor to tumor (well differentiated to poorly differentiated tumors). Hepatocellular carcinomas quickly metastasize to regional lymph nodes and lung. The overall median survival of untreated liver cell carcinoma is about 4 months. The most effective treatment of hepatocellular carcinoma is complete resection of the tumor. Lately, an increasing number of tumors have been treated with liver transplantation._Pathologic; caused by or altered by or manifesting disease or pathology._One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"2834593v1.0:2207099v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2834593","version":"1","preferredName":"Hepatocellular Carcinoma","preferredDefinition":"A malignant tumor that arises from hepatocytes. Hepatocellular carcinoma is relatively rare in the United States but very common in all African countries south of the Sahara and in Southeast Asia. Most cases are seen in patients over the age of 50 years, but this tumor can also occur in younger individuals and even in children. Hepatocellular carcinoma is more common in males than females and is associated with hepatitis B, hepatitis C, chronic alcohol abuse and cirrhosis. Serum elevation of alpha-fetoprotein occurs in a large percentage of patients with hepatocellular carcinoma. Grossly, hepatocellular carcinoma may present as a single mass, as multiple nodules, or as diffuse liver involvement. Microscopically, there is a wide range of differentiation from tumor to tumor (well differentiated to poorly differentiated tumors). Hepatocellular carcinomas quickly metastasize to regional lymph nodes and lung. The overall median survival of untreated liver cell carcinoma is about 4 months. The most effective treatment of hepatocellular carcinoma is complete resection of the tumor. Lately, an increasing number of tumors have been treated with liver transplantation.","longName":"C3099","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatocellular Carcinoma","conceptCode":"C3099","definition":"A malignant tumor that arises from hepatocytes. Hepatocellular carcinoma is relatively rare in the United States but very common in all African countries south of the Sahara and in Southeast Asia. Most cases are seen in patients over the age of 50 years, but this tumor can also occur in younger individuals and even in children. Hepatocellular carcinoma is more common in males than females and is associated with hepatitis B, hepatitis C, chronic alcohol abuse and cirrhosis. Serum elevation of alpha-fetoprotein occurs in a large percentage of patients with hepatocellular carcinoma. Grossly, hepatocellular carcinoma may present as a single mass, as multiple nodules, or as diffuse liver involvement. Microscopically, there is a wide range of differentiation from tumor to tumor (well differentiated to poorly differentiated tumors). Hepatocellular carcinomas quickly metastasize to regional lymph nodes and lung. The overall median survival of untreated liver cell carcinoma is about 4 months. The most effective treatment of hepatocellular carcinoma is complete resection of the tumor. Lately, an increasing number of tumors have been treated with liver transplantation.","evsSource":"UMLS_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62421A44-5466-782E-E040-BB89AD437669","latestVersionIndicator":"Yes","beginDate":"2009-02-06","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2009-02-06","modifiedBy":"ONEDATA","dateModified":"2009-02-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207099","version":"1","preferredName":"Pathologic T Stage","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"C25610:C25728","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-1838-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"98A7B501-CBC3-2349-E040-BB89AD430DBA","latestVersionIndicator":"Yes","beginDate":"2010-12-30","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-30","modifiedBy":"TAYLORT","dateModified":"2018-12-19","changeDescription":"12/19/18 TT transferred ownership from NCIP to NCI Standards. Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3376979","version":"1","preferredName":"Liver Cancer American Joint Committee on Cancer (AJCC) Edition 7 T Stage","preferredDefinition":"A finding about one or more characteristics of liver cancer, following the rules of the TNM AJCC v7 classification system.  Intrahepatic bile duct cancers are no longer included in this classification.  The staging of liver cancer now includes only hepatocellular carcinoma. (from AJCC 7th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion)._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3376979v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"T4","valueDescription":"Liver Cancer pT4 TNM Finding v7","ValueMeaning":{"publicId":"3179617","version":"1","preferredName":"Liver Cancer pT4 TNM Finding v7","longName":"3179617","preferredDefinition":"Liver cancer with tumor(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liver Cancer pT4 TNM Finding v7","conceptCode":"C90163","definition":"Liver cancer with tumor(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum. (from AJCC 7th Ed.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98A836E8-AB4C-B596-E040-BB89AD434903","latestVersionIndicator":"Yes","beginDate":"2010-12-30","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B89D8F4D-4C67-28AE-E040-BB89AD43501B","beginDate":"2012-02-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-10","modifiedBy":"ONEDATA","dateModified":"2012-02-10","deletedIndicator":"No"},{"value":"T3b","valueDescription":"Liver Cancer pT3b TNM Finding v7","ValueMeaning":{"publicId":"3179619","version":"1","preferredName":"Liver Cancer pT3b TNM Finding v7","longName":"3179619","preferredDefinition":"Liver cancer with single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic vein. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liver Cancer pT3b TNM Finding v7","conceptCode":"C90162","definition":"Liver cancer with single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic vein. (from AJCC 7th Ed.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98A836E8-AB72-B596-E040-BB89AD434903","latestVersionIndicator":"Yes","beginDate":"2010-12-30","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B89D8F4D-4C7C-28AE-E040-BB89AD43501B","beginDate":"2012-02-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-10","modifiedBy":"ONEDATA","dateModified":"2012-02-10","deletedIndicator":"No"},{"value":"T3a","valueDescription":"Liver Cancer pT3a TNM Finding v7","ValueMeaning":{"publicId":"3179621","version":"1","preferredName":"Liver Cancer pT3a TNM Finding v7","longName":"3179621","preferredDefinition":"Liver cancer with multiple tumors more than 5 cm in greatest dimension. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liver Cancer pT3a TNM Finding v7","conceptCode":"C90161","definition":"Liver cancer with multiple tumors more than 5 cm in greatest dimension. (from AJCC 7th Ed.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98A836E8-AB98-B596-E040-BB89AD434903","latestVersionIndicator":"Yes","beginDate":"2010-12-30","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B89D8F4D-4C91-28AE-E040-BB89AD43501B","beginDate":"2012-02-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-10","modifiedBy":"ONEDATA","dateModified":"2012-02-10","deletedIndicator":"No"},{"value":"T2","valueDescription":"Liver Cancer pT2 TNM Finding v7","ValueMeaning":{"publicId":"3179623","version":"1","preferredName":"Liver Cancer pT2 TNM Finding v7","longName":"3179623","preferredDefinition":"Liver cancer with solitary tumor with vascular invasion or multiple tumors none more than 5 cm in greatest dimension. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liver Cancer pT2 TNM Finding v7","conceptCode":"C90160","definition":"Liver cancer with solitary tumor with vascular invasion or multiple tumors none more than 5 cm in greatest dimension. (from AJCC 7th Ed.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98A836E8-ABBE-B596-E040-BB89AD434903","latestVersionIndicator":"Yes","beginDate":"2010-12-30","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B89D8F4D-4CA6-28AE-E040-BB89AD43501B","beginDate":"2012-02-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-10","modifiedBy":"ONEDATA","dateModified":"2012-02-10","deletedIndicator":"No"},{"value":"T1","valueDescription":"Liver Cancer pT1 TNM Finding v7","ValueMeaning":{"publicId":"3179625","version":"1","preferredName":"Liver Cancer pT1 TNM Finding v7","longName":"3179625","preferredDefinition":"Liver cancer with solitary tumor without vascular invasion. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liver Cancer pT1 TNM Finding v7","conceptCode":"C90159","definition":"Liver cancer with solitary tumor without vascular invasion. (from AJCC 7th Ed.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98A836E8-ABE4-B596-E040-BB89AD434903","latestVersionIndicator":"Yes","beginDate":"2010-12-30","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B89D8F4D-4CBB-28AE-E040-BB89AD43501B","beginDate":"2012-02-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-10","modifiedBy":"ONEDATA","dateModified":"2012-02-10","deletedIndicator":"No"},{"value":"T0","valueDescription":"Liver Cancer pT0 TNM Finding v7","ValueMeaning":{"publicId":"3179627","version":"1","preferredName":"Liver Cancer pT0 TNM Finding v7","longName":"3179627","preferredDefinition":"Liver cancer with no evidence of a primary tumor. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liver Cancer pT0 TNM Finding v7","conceptCode":"C90158","definition":"Liver cancer with no evidence of a primary tumor. (from AJCC 7th Ed.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98A836E8-AC0A-B596-E040-BB89AD434903","latestVersionIndicator":"Yes","beginDate":"2010-12-30","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B89D8F4D-4CD0-28AE-E040-BB89AD43501B","beginDate":"2012-02-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-10","modifiedBy":"ONEDATA","dateModified":"2012-02-10","deletedIndicator":"No"},{"value":"TX","valueDescription":"Liver Cancer pTX TNM Finding v7","ValueMeaning":{"publicId":"3179629","version":"1","preferredName":"Liver Cancer pTX TNM Finding v7","longName":"3179629","preferredDefinition":"Liver cancer in which the primary tumor cannot be assessed. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liver Cancer pTX TNM Finding v7","conceptCode":"C90156","definition":"Liver cancer in which the primary tumor cannot be assessed. (from AJCC 7th Ed.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98A836E8-AC30-B596-E040-BB89AD434903","latestVersionIndicator":"Yes","beginDate":"2010-12-30","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B89D8F4D-4CE5-28AE-E040-BB89AD43501B","beginDate":"2012-02-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-10","modifiedBy":"ONEDATA","dateModified":"2012-02-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3376978","version":"1","preferredName":"Liver Cancer TNM Finding v7 American Joint Committee on Cancer T Stage Stage","preferredDefinition":"A finding about one or more characteristics of liver cancer, following the rules of the TNM AJCC v7 classification system.  Intrahepatic bile duct cancers are no longer included in this classification.  The staging of liver cancer now includes only hepatocellular carcinoma. (from AJCC 7th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C90149:C39315:C25728:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liver Cancer TNM Finding v7","conceptCode":"C90149","definition":"A finding about one or more characteristics of liver cancer, following the rules of the TNM AJCC v7 classification system.  Intrahepatic bile duct cancers are no longer included in this classification.  The staging of liver cancer now includes only hepatocellular carcinoma. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B89D8F4D-4C34-28AE-E040-BB89AD43501B","latestVersionIndicator":"Yes","beginDate":"2012-02-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-10","modifiedBy":"ONEDATA","dateModified":"2012-02-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B89D8F4D-4C45-28AE-E040-BB89AD43501B","latestVersionIndicator":"Yes","beginDate":"2012-02-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-10","modifiedBy":"COOPERM","dateModified":"2012-05-07","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3434440","version":"1","longName":"Liver","context":"NCIP"},{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"10000291","version":"1","longName":"Liver","context":"NCI Standards"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000689","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCI Standards"}]}],"AlternateNames":[{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"}],"ReferenceDocuments":[{"name":"Pathologic T Stage","type":"Preferred Question Text","description":"Pathologic T Stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"B8A161ED-BBB2-562C-E040-BB89AD430F80","latestVersionIndicator":"Yes","beginDate":"2012-02-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-10","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}